49 / 126
INTERNATIONAL STAKEHOLDER PANEL ON ALTERNATIVE
METHODS (ISPAM)
Gregory Noonan, Ph.D.
US Food & Drug Administration (FDA)
Dr. Gregory Noonan joined the US Food and Drug Administration in 2002 and is
currently the Director of the Division of Bioanalytical Chemistry (DBC) in the
Office of Regulatory Science. The Division of Bioanalytical Chemistry contains
over 35 scientists performing research and developing analytical methods in
numerous subject areas, including, toxic elements analysis, immunodiagnostic
and DNA-based allergen detection, radionuclides, pesticide analysis, mycotoxin analysis, dietary
supplements and botanicals, nutritional ingredients and cosmetics. Prior to becoming Director, Dr.
Noonan was a Research Chemist in the Method Development Branch of the Division of Analytical
Chemistry. His research focused on developing methods for the determination of food additives,
including indirect additives, and process induced contaminants. Dr. Noonan also serves as the US
Delegate to the Codex Committee on Methods of Analysis and Sampling (CCMAS), where he chairs the
Working Group on the Endorsement of Methods. Dr. Noonan received his PhD in Chemistry from
Michigan State University in 1996. After graduation he worked for the Diagnostic Division of Abbott
Laboratories, where he developed diagnostic immunoassays for Hepatitis A, B and C and HIV. After
leaving Abbott Laboratories and prior to joining the FDA, he left was a postdoctoral fellow in the Civil and
Environmental Engineering department of the Massachusetts Institute of Technology, where he studied
the fate and transport of polar, water soluble environmental contaminants.